These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 9515022

  • 1. Altered cardiac annexin mRNA and protein levels in the left ventricle of patients with end-stage heart failure.
    Song G, Campos B, Wagoner LE, Dedman JR, Walsh RA.
    J Mol Cell Cardiol; 1998 Mar; 30(3):443-51. PubMed ID: 9515022
    [Abstract] [Full Text] [Related]

  • 2. Expression and localization of the annexins II, V, and VI in myocardium from patients with end-stage heart failure.
    Benevolensky D, Belikova Y, Mohammadzadeh R, Trouvé P, Marotte F, Russo-Marie F, Samuel JL, Charlemagne D.
    Lab Invest; 2000 Feb; 80(2):123-33. PubMed ID: 10701682
    [Abstract] [Full Text] [Related]

  • 3. Annexins, calcium-dependent phospholipid binding proteins in irreducible heart failure.
    Branishte T, Arsenescu-Georgescu C, Tomescu MC, Braniste A, Mitu F.
    Rev Med Chir Soc Med Nat Iasi; 2013 Feb; 117(3):648-53. PubMed ID: 24502030
    [Abstract] [Full Text] [Related]

  • 4. Annexins and Ca2+ handling in the heart.
    Camors E, Monceau V, Charlemagne D.
    Cardiovasc Res; 2005 Mar 01; 65(4):793-802. PubMed ID: 15721859
    [Abstract] [Full Text] [Related]

  • 5. Presence and comparison of Ca2+ transport activity of annexins I, II, V, and VI in large unilamellar vesicles.
    Matsuda R, Kaneko N, Horikawa Y.
    Biochem Biophys Res Commun; 1997 Aug 28; 237(3):499-503. PubMed ID: 9299392
    [Abstract] [Full Text] [Related]

  • 6. Altered connexin expression in human congestive heart failure.
    Dupont E, Matsushita T, Kaba RA, Vozzi C, Coppen SR, Khan N, Kaprielian R, Yacoub MH, Severs NJ.
    J Mol Cell Cardiol; 2001 Feb 28; 33(2):359-71. PubMed ID: 11162139
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin II receptor type 1 mRNA is upregulated in atria of patients with end-stage heart failure.
    Kaprielian RR, Dupont E, Hafizi S, Poole-Wilson PA, Khaghani A, Yacoub MH, Severs NJ.
    J Mol Cell Cardiol; 1997 Aug 28; 29(8):2299-304. PubMed ID: 9281460
    [Abstract] [Full Text] [Related]

  • 8. Localization and quantitation of cardiac annexins II, V, and VI in hypertensive guinea pigs.
    Trouvé P, Legot S, Bélikova I, Marotte F, Bénévolensky D, Russo-Marie F, Samuel JL, Charlemagne D.
    Am J Physiol; 1999 Apr 28; 276(4):H1159-66. PubMed ID: 10199838
    [Abstract] [Full Text] [Related]

  • 9. Heterogeneity and timing of translocation and membrane-mediated assembly of different annexins.
    Skrahina T, Piljić A, Schultz C.
    Exp Cell Res; 2008 Mar 10; 314(5):1039-47. PubMed ID: 18164291
    [Abstract] [Full Text] [Related]

  • 10. Upregulation of annexins I, II, and V after traumatic spinal cord injury in adult rats.
    Liu N, Han S, Lu PH, Xu XM.
    J Neurosci Res; 2004 Aug 01; 77(3):391-401. PubMed ID: 15248295
    [Abstract] [Full Text] [Related]

  • 11. Annexin VI regulation of cardiac function.
    Kaetzel MA, Dedman JR.
    Biochem Biophys Res Commun; 2004 Oct 01; 322(4):1171-7. PubMed ID: 15336965
    [Abstract] [Full Text] [Related]

  • 12. Immunolocalization of annexins IV, V and VI in the failing and non-failing human heart.
    Matteo RG, Moravec CS.
    Cardiovasc Res; 2000 Mar 01; 45(4):961-70. PubMed ID: 10728422
    [Abstract] [Full Text] [Related]

  • 13. Regional expression and functional characterization of the L-type Ca2+-channel in myocardium from patients with end-stage heart failure and in non-failing human hearts.
    Schwinger RH, Hoischen S, Reuter H, Hullin R.
    J Mol Cell Cardiol; 1999 Jan 01; 31(1):283-96. PubMed ID: 10072735
    [Abstract] [Full Text] [Related]

  • 14. Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure.
    Mercadier JJ, Lompré AM, Duc P, Boheler KR, Fraysse JB, Wisnewsky C, Allen PD, Komajda M, Schwartz K.
    J Clin Invest; 1990 Jan 01; 85(1):305-9. PubMed ID: 2136864
    [Abstract] [Full Text] [Related]

  • 15. Messenger RNA expression and immunological quantification of phospholamban and SR-Ca(2+)-ATPase in failing and nonfailing human hearts.
    Linck B, Bokník P, Eschenhagen T, Müller FU, Neumann J, Nose M, Jones LR, Schmitz W, Scholz H.
    Cardiovasc Res; 1996 Apr 01; 31(4):625-32. PubMed ID: 8689655
    [Abstract] [Full Text] [Related]

  • 16. Localization of annexin V in the adult and neonatal heart.
    Luckcuck T, Trotter PJ, Walker JH.
    Biochem Biophys Res Commun; 1997 Sep 18; 238(2):622-8. PubMed ID: 9299563
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cholesterol enhances phospholipid binding and aggregation of annexins by their core domain.
    Ayala-Sanmartin J.
    Biochem Biophys Res Commun; 2001 Apr 27; 283(1):72-9. PubMed ID: 11322769
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of matrix metalloproteinase-9 (MMP-9) expression in the myocardium of congestive heart failure patients.
    Batlle M, Pérez-Villa F, García-Pras E, Lázaro A, Orús J, Roqué M, Roig E.
    Transplant Proc; 2007 Sep 27; 39(7):2344-6. PubMed ID: 17889183
    [Abstract] [Full Text] [Related]

  • 20. Association of annexin A5 with Na+/Ca2+ exchanger and caveolin-3 in non-failing and failing human heart.
    Camors E, Charue D, Trouvé P, Monceau V, Loyer X, Russo-Marie F, Charlemagne D.
    J Mol Cell Cardiol; 2006 Jan 27; 40(1):47-55. PubMed ID: 16330044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.